Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Dybul

Showing results (31-40 of 64) with videos related to

Pageof 7
Sort By:
Lancet (London, England)|July 22, 2014
Maximising the effect of combination HIV prevention through prioritisation of the people and places in greatest need: a modelling studySarah-Jane Anderson, Peter Cherutich, Nduku Kilonzo, et al.
The Journal of Infectious Diseases|June 27, 2002
Evaluation of initial CD4+ T cell counts in individuals with newly diagnosed human immunodeficiency virus infection, by sex and race, in urban settingsMark Dybul, Robert Bolan, David Condoluci, et al.
AIDS (London, England)|December 17, 2010
Association of aging and survival in a large HIV-infected cohort on antiretroviral therapyCelestin Bakanda, Josephine Birungi, Robert Mwesigwa, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|July 11, 2017
Ending cervical cancer: A call to actionSanchia Aranda, Seth Berkley, Sally Cowal, et al.
Journal of Virology|August 7, 2002
Human immunodeficiency virus type 1 bound to B cells: relationship to virus replicating in CD4+ T cells and circulating in plasmaAngela Malaspina, Susan Moir, David C Nickle, et al.
Lancet (London, England)|June 21, 2024
Political courage needed to prevent the next pandemicHelen Clark, Mauricio Cárdenas, Mark Dybul, et al.
BMJ Global Health|June 17, 2026
Africa's ownership of a sustainable health journey towards an AIDS-free futureMumbi Chola, Magda Robalo, Kent Buse, et al.
Lancet (London, England)|June 29, 2015
Defeating AIDS--advancing global healthPeter Piot, Salim S Abdool Karim, Robert Hecht, et al.
The Journal of Infectious Diseases|January 5, 2002
Pilot study of the effects of intermittent interleukin-2 on human immunodeficiency virus (HIV)-specific immune responses in patients treated during recently acquired HIV infectionMark Dybul, Bertha Hidalgo, Tae-Wook Chun, et al.
Lancet (London, England)|April 18, 2014
Transformation of HIV from pandemic to low-endemic levels: a public health approach to combination preventionAlexandra Jones, Ide Cremin, Fareed Abdullah, et al.
Pageof 7

Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
Lancet (London, England)|July 22, 2014
Maximising the effect of combination HIV prevention through prioritisation of the people and places in greatest need: a modelling studySarah-Jane Anderson, Peter Cherutich, Nduku Kilonzo, et al.
The Journal of Infectious Diseases|June 27, 2002
Evaluation of initial CD4+ T cell counts in individuals with newly diagnosed human immunodeficiency virus infection, by sex and race, in urban settingsMark Dybul, Robert Bolan, David Condoluci, et al.
AIDS (London, England)|December 17, 2010
Association of aging and survival in a large HIV-infected cohort on antiretroviral therapyCelestin Bakanda, Josephine Birungi, Robert Mwesigwa, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|July 11, 2017
Ending cervical cancer: A call to actionSanchia Aranda, Seth Berkley, Sally Cowal, et al.
Journal of Virology|August 7, 2002
Human immunodeficiency virus type 1 bound to B cells: relationship to virus replicating in CD4+ T cells and circulating in plasmaAngela Malaspina, Susan Moir, David C Nickle, et al.
Lancet (London, England)|June 21, 2024
Political courage needed to prevent the next pandemicHelen Clark, Mauricio Cárdenas, Mark Dybul, et al.
BMJ Global Health|June 17, 2026
Africa's ownership of a sustainable health journey towards an AIDS-free futureMumbi Chola, Magda Robalo, Kent Buse, et al.
Lancet (London, England)|June 29, 2015
Defeating AIDS--advancing global healthPeter Piot, Salim S Abdool Karim, Robert Hecht, et al.
The Journal of Infectious Diseases|January 5, 2002
Pilot study of the effects of intermittent interleukin-2 on human immunodeficiency virus (HIV)-specific immune responses in patients treated during recently acquired HIV infectionMark Dybul, Bertha Hidalgo, Tae-Wook Chun, et al.
Lancet (London, England)|April 18, 2014
Transformation of HIV from pandemic to low-endemic levels: a public health approach to combination preventionAlexandra Jones, Ide Cremin, Fareed Abdullah, et al.
Pageof 7